Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioRestorative Therapies Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BRTX
Nasdaq
8731
https://www.biorestorative.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioRestorative Therapies Inc
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
- Apr 30th, 2024 8:15 pm
BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
- Apr 30th, 2024 11:30 am
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
- Apr 16th, 2024 11:45 am
10 Micro-Cap Healthcare Stocks Insiders Are Buying
- Apr 14th, 2024 7:00 pm
BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
- Apr 8th, 2024 11:45 am
BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants
- Apr 3rd, 2024 8:38 pm
BioRestorative Therapies Full Year 2023 Earnings: Beats Expectations
- Apr 3rd, 2024 10:51 am
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
- Apr 1st, 2024 11:45 am
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
- Mar 11th, 2024 8:15 pm
Favourable Signals For BioRestorative Therapies: Numerous Insiders Acquired Stock
- Feb 15th, 2024 10:20 am
BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting
- Feb 14th, 2024 2:15 pm
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
- Feb 6th, 2024 1:05 pm
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
- Feb 5th, 2024 12:30 pm
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
- Feb 1st, 2024 12:30 pm
BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program
- Dec 12th, 2023 2:15 pm
11 Most Volatile Stocks Under $5 For Day Trading
- Dec 3rd, 2023 6:11 pm
BioRestorative Therapies, Inc. to Participate at the ROTH MKM Healthcare Opportunities Conference October 12, 2023 in New York City
- Oct 9th, 2023 4:10 pm
QIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software
- Oct 2nd, 2023 1:14 pm
Roth MKM Analyst Projects An Impressive Price Target of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says “Low Valuation Undeserved”
- Sep 18th, 2023 1:00 pm
EXCLUSIVE: Stem Cell Focused BioRestorative Ventures Into $63B Aesthetics Market Via Supply Agreement With Evolutionary Biologics
- Sep 12th, 2023 2:30 pm
Scroll